Cybin to Present at the Benzinga Psychedelics Capital Conference in Miami on April 19, 2022

Rhea-AI Summary

Cybin announces participation in the Benzinga Psychedelics Capital Conference on April 19, 2022. CEO Doug Drysdale will engage in a fireside chat at 1:10 p.m. ET and a panel discussion at 3:10 p.m. ET focused on catalysts in the psychedelics industry. The event will be streamed live, and recordings will be available on the company’s investor relations website. Founded in 2019, Cybin is a biopharmaceutical firm dedicated to creating effective therapeutics for mental health issues, operating in multiple countries including Canada and the U.S.

TORONTO--(BUSINESS WIRE)-- Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics^™” is pleased to announce that Doug Drysdale, Cybin’s Chief Executive Officer, will participate in a fireside chat and panel discussion at the Benzinga Psychedelics Capital Conference being held at the Fontainebleau Miami Beach on Tuesday, April 19, 2022.

Mr. Drysdale’s fireside chat will be webcast live on Tuesday, April 19 at 1:10 p.m. ET. In addition, Mr. Drysdale will participate in a panel discussion titled “Short, Medium, and Long Term Catalysts in Psychedelics” taking place at 3:10 p.m. ET on Tuesday, April 19.

To listen to the fireside chat and the panel, please click here to access the event livestream. The archived webcasts will also be available on the Company’s investor relations website on the Events & Presentations page.

About Cybin

Cybin is a leading ethical biopharmaceutical company, working with a network of world-class partners and internationally recognized scientists, on a mission to create safe and effective therapeutics for patients to address a multitude of mental health issues. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, United Kingdom and Ireland. The Company is focused on progressing Psychedelics to Therapeutics^™ by engineering proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for mental health disorders.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220406005313/en/

Investors & Media:

Leah Gibson

Vice President, Investor Relations & Strategic Communications

Cybin Inc.

leah@cybin.com

Source: Cybin Inc.

FAQ

When is Cybin's participation in the Benzinga Psychedelics Capital Conference?

Cybin will participate in the Benzinga Psychedelics Capital Conference on April 19, 2022.

What time will Doug Drysdale's fireside chat take place?

Doug Drysdale's fireside chat will take place at 1:10 p.m. ET on April 19, 2022.

What topics will be discussed during the panel involving Cybin's CEO?

The panel discussion will focus on 'Short, Medium, and Long Term Catalysts in Psychedelics' on April 19, 2022.

How can I access the livestream of the Benzinga Psychedelics Capital Conference featuring Cybin?

The livestream can be accessed by clicking on the link provided in the press release.

What is Cybin's mission in the biopharmaceutical industry?

Cybin's mission is to create safe and effective therapeutics for addressing mental health issues.